KEROS THERAPEUTICS IN
60,09
08-октября-24 10:38:19
15 мин. задержка
Акции
-0,03
-0,06%
Сегодняшний диапазон
59,95 - 61,00
ISIN
N/A
Источник
NASDAQ
- Котировки
- Графики
Новости
- Статистика
-
12 сен 2024 08:00:00 Источник Nasdaq GlobeNewswire
-
Keros Therapeutics Announces Update on Enrollment in the Phase 2 TROPOS Trial
03 сен 2024 08:00:00 Источник Nasdaq GlobeNewswire
-
Keros Therapeutics Announces Participation at Upcoming Healthcare Conferences
28 авг 2024 08:00:00 Источник Nasdaq GlobeNewswire
-
Keros Therapeutics Reports Second Quarter 2024 Financial Results
07 авг 2024 16:01:00 Источник Nasdaq GlobeNewswire
-
Keros Therapeutics Announces Leadership Updates
17 июн 2024 16:01:02 Источник Nasdaq GlobeNewswire
-
17 июн 2024 06:00:00 Источник Nasdaq GlobeNewswire
-
Keros Therapeutics to Host a Corporate Update Conference Call and Webcast
04 июн 2024 08:00:00 Источник Nasdaq GlobeNewswire
-
Keros Therapeutics to Present at Goldman Sachs 45th Annual Global Healthcare Conference
03 июн 2024 08:00:00 Источник Nasdaq GlobeNewswire
-
Keros Therapeutics Appoints Jean-Jacques Bienaimé to its Board of Directors
28 май 2024 16:01:00 Источник Nasdaq GlobeNewswire
-
Keros Therapeutics to Present at the 29th Annual Congress of the European Hematology Association
14 май 2024 10:00:00 Источник Nasdaq GlobeNewswire
-
Keros Therapeutics Reports Recent Business Highlights and First Quarter 2024 Financial Results
08 май 2024 08:00:00 Источник Nasdaq GlobeNewswire
-
14 мар 2024 08:00:00 Источник Nasdaq GlobeNewswire
-
Keros Therapeutics to Present at Leerink Partners 2024 Global Biopharma Conference
05 мар 2024 08:00:00 Источник Nasdaq GlobeNewswire
-
28 фев 2024 16:01:00 Источник Nasdaq GlobeNewswire
-
Keros Therapeutics To Present at Pulmonary Vascular Research Institute 2024 Annual Congress
29 янв 2024 08:00:00 Источник Nasdaq GlobeNewswire
-
Keros Therapeutics Announces Closing of Upsized Public Offering of Common Stock
09 янв 2024 08:00:00 Источник Nasdaq GlobeNewswire
-
Keros Therapeutics Announces Pricing of Upsized Public Offering of Common Stock
03 янв 2024 21:29:25 Источник Nasdaq GlobeNewswire
-
Keros Therapeutics Announces Proposed Public Offering of Common Stock
03 янв 2024 16:05:39 Источник Nasdaq GlobeNewswire
-
Keros Therapeutics to Develop KER-065 for the Treatment of Obesity
03 янв 2024 08:00:00 Источник Nasdaq GlobeNewswire
-
11 дек 2023 06:00:00 Источник Nasdaq GlobeNewswire
- <<
- <
- 1
- >